Benzinga | Jul 29, 2021 05:14PM EDT

Bio-Rad Laboratories Q2 EPS $3.54 Beats $2.66 Estimate, Sales $715.93M Beat $631.78M Estimate

Bio-Rad Laboratories (NYSE:BIO) reported quarterly earnings of $3.54 per share which beat the analyst consensus estimate of $2.66 by 33.08 percent. This is a 119.88 percent increase over earnings of $1.61 per share from the same period last year. The company reported quarterly sales of $715.93 million which beat the analyst consensus estimate of $631.78 million by 13.32 percent. This is a 33.35 percent increase over sales of $536.88 million the same period last year.